Open-Label Natalizumab Safety Extension Study

Clinical trial NCT00276172 · COMPLETED

Trial details

NCT number: NCT00276172
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2003-12-01
Primary completion: 2005-10-01
Enrollment: 1615

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.